Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PALVELLA THERAPEUTICS, INC. | Director | Common Stock | 183K | $3.69M | $20.13 | Apr 9, 2025 | Direct |
PALVELLA THERAPEUTICS, INC. | Director | Common Stock | 13.5K | $274K | $20.27 | Apr 9, 2025 | by foundation |
PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 24.7K | Dec 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVLA | PALVELLA THERAPEUTICS, INC. | Apr 9, 2025 | 2 | $101K | 4 | Apr 10, 2025 | Director |
PVLA | PALVELLA THERAPEUTICS, INC. | Dec 18, 2024 | 1 | $51.7K | 4 | Dec 19, 2024 | Director |
PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 1 | $0 | 4 | Dec 17, 2024 | Director |
PVLA | PALVELLA THERAPEUTICS, INC. | Dec 13, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Director |